154 related articles for article (PubMed ID: 16609368)
1. Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.
Jiang Z; Dragin N; Jorge-Nebert LF; Martin MV; Guengerich FP; Aklillu E; Ingelman-Sundberg M; Hammons GJ; Lyn-Cook BD; Kadlubar FF; Saldana SN; Sorter M; Vinks AA; Nassr N; von Richter O; Jin L; Nebert DW
Pharmacogenet Genomics; 2006 May; 16(5):359-67. PubMed ID: 16609368
[TBL] [Abstract][Full Text] [Related]
2. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
[TBL] [Abstract][Full Text] [Related]
3. Comparison of linkage disequilibrium patterns and haplotype structure of eight single nucleotide polymorphisms across the CYP1A2 gene between the Korean, and other populations registered in the International HapMap database.
Woo SW; Kang TS; Park HJ; Lee JE; Roh J
J Clin Pharm Ther; 2009 Aug; 34(4):429-36. PubMed ID: 19583676
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection.
Wooding SP; Watkins WS; Bamshad MJ; Dunn DM; Weiss RB; Jorde LB
Am J Hum Genet; 2002 Sep; 71(3):528-42. PubMed ID: 12181774
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
[TBL] [Abstract][Full Text] [Related]
7. Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
Jorge-Nebert LF; Zhang G; Wilson KM; Jiang Z; Butler R; Gluckman JL; Pinney SM; Nebert DW
Hum Genomics; 2016 Nov; 10(1):39. PubMed ID: 27894333
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers.
Oliver P; Lubomirov R; Carcas A
Clin Chem Lab Med; 2010 May; 48(5):635-9. PubMed ID: 20218903
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
[TBL] [Abstract][Full Text] [Related]
10. Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.
Söderberg MM; Haslemo T; Molden E; Dahl ML
Pharmacogenet Genomics; 2013 May; 23(5):279-85. PubMed ID: 23492908
[TBL] [Abstract][Full Text] [Related]
11. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.
Soyama A; Saito Y; Hanioka N; Maekawa K; Komamura K; Kamakura S; Kitakaze M; Tomoike H; Ueno K; Goto Y; Kimura H; Katoh M; Sugai K; Saitoh O; Kawai M; Ohnuma T; Ohtsuki T; Suzuki C; Minami N; Kamatani N; Ozawa S; Sawada J
Drug Metab Pharmacokinet; 2005 Feb; 20(1):24-33. PubMed ID: 15770072
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of CYP1A2, novel polymorphisms and haplotypes in three distinct Asian populations.
Lim JS; Singh O; Ramasamy RD; Ramasamy S; Subramanian K; Lee EJ; Chowbay B
Drug Metab Pharmacokinet; 2010; 25(6):616-23. PubMed ID: 20930417
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki SMA
PLoS One; 2017; 12(9):e0183424. PubMed ID: 28934216
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations.
Jorge-Nebert LF; Jiang Z; Chakraborty R; Watson J; Jin L; McGarvey ST; Deka R; Nebert DW
Hum Mutat; 2010 Jan; 31(1):27-40. PubMed ID: 19802894
[TBL] [Abstract][Full Text] [Related]
16. CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzyme.
Browning SL; Tarekegn A; Bekele E; Bradman N; Thomas MG
Pharmacogenet Genomics; 2010 Nov; 20(11):647-64. PubMed ID: 20881513
[TBL] [Abstract][Full Text] [Related]
17. Associations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population.
Matakova T; Halasova E; Dzian A; Hruby R; Halasa M; Javorka K; Skerenova M
Adv Exp Med Biol; 2016; 911():23-32. PubMed ID: 26987327
[TBL] [Abstract][Full Text] [Related]
18. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
Skarke C; Kirchhof A; Geisslinger G; Lötsch J
Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
[TBL] [Abstract][Full Text] [Related]
19. Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population.
Adehin A; Bolaji OO; Maggo S; Kennedy MA
Drug Metab Pers Ther; 2017 Mar; 32(1):39-47. PubMed ID: 28231062
[TBL] [Abstract][Full Text] [Related]
20. Identification of non-functional allelic variant of CYP1A2 in dogs.
Mise M; Hashizume T; Matsumoto S; Terauchi Y; Fujii T
Pharmacogenetics; 2004 Nov; 14(11):769-73. PubMed ID: 15564884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
